Latest Company Filings News

Sarama Resources has raised A$2.7 million to fund exploration at its Australian gold projects while progressing a significant arbitration claim against Burkina Faso for expropriation of its African permit.

Sarama Resources Ltd reported a $1.9 million loss for the first nine months of 2025 while securing A$2.7 million in equity funding and advancing a $242 million arbitration claim against Burkina Faso over mining permit expropriation.

Cassius Mining Limited reports steady progress on its Soalara Limestone Project joint venture discussions and updates on its international arbitration case against Ghana, while raising $250,000 through share and convertible note issuances.

Grange Resources reported a robust Q3 2025 with increased iron ore concentrate production, improved pellet sales, and a notable rise in realised product pricing, all while maintaining an excellent safety record.

Orezone Gold Corporation reported solid Q3-2025 gold production amid weather challenges and is on track to commission its stage 1 hard rock expansion at Bomboré, aiming for a significant production increase next year.

Austral Gold has resumed commercial production at its Casposo Mine in Argentina after completing a significant plant refurbishment, aiming to boost its output alongside operations in Chile.

Paladin Energy reports a record uranium production quarter at its Langer Heinrich Mine alongside a robust engineering review of its Patterson Lake South Project, supported by a successful A$300 million equity raise.

Paladin Energy reported a record uranium production quarter at its Langer Heinrich Mine alongside a successful A$300 million equity raise, positioning the company for accelerated development of its Patterson Lake South project.

Boab Metals Limited has responded to ASX concerns over recent unusual trading activity, confirming no undisclosed information exists and attributing the surge to positive research reports and rising silver prices.

Maronan Metals Limited has had its trading suspension lifted immediately following the release of its Preliminary Economic Assessment, signaling renewed market activity.

Race Oncology has uncovered that its anticancer drug bisantrene exists as three light-sensitive isomers, with only one showing potent activity. The company has filed patents to protect this active form, potentially extending its intellectual property rights until 2045.

Andromeda Metals has addressed a recent spike in its share price and trading volume, attributing the movement to a newly released research report and an imminent High Purity Alumina scoping study.